Literature DB >> 26898397

Acute Limb-Threatening Ischemia Associated With Antiphospholipid Syndrome: A Report of Two Cases.

Kiwako Suzuki1, Tetsuji Uemura2, Mamoru Kikuchi3, Yasuhiro Ishihara4, Shigeru Ichioka5.   

Abstract

Acute limb ischemia results from sudden deterioration in the arterial supply to the limb, occasionally leading to limb loss or fatality. Antiphospholipid syndrome (APS) is known to induce acute limb ischemia among the various etiologies responsible for arterial obstruction. APS is a systemic autoimmune disorder characterized by a combination of arterial and/or venous thrombosis and limb loss. It is often accompanied by a mild-to-moderate thrombocytopenia and elevated titers of antiphospholipid antibodies, including the lupus anticoagulant and the anticardiolipin antibodies. In the present report, we present 2 cases of acute limb ischemia due to APS associated with systemic lupus erythematosus. Angiography revealed arterial obstruction distal to the popliteal artery in both patients, and each patient eventually underwent below-the-knee amputation. Surgeons treating acute limb ischemia should remember APS, although this disease might not be common in daily clinical practice.
Copyright © 2016 American College of Foot and Ankle Surgeons. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  acute arterial occlusion; antiphospholipid syndrome; major amputation; systemic lupus erythematosus

Mesh:

Year:  2016        PMID: 26898397     DOI: 10.1053/j.jfas.2016.01.002

Source DB:  PubMed          Journal:  J Foot Ankle Surg        ISSN: 1067-2516            Impact factor:   1.286


  2 in total

1.  Abdominal pain in patient with antiphospholipid syndrome-the role of MDCT angiography on visceral blood vessels.

Authors:  Jovica Saponjski; Ljudmila Stojanovich; Jelena Saponjski; Milorad Mirilovic; Dusan Saponjski
Journal:  Immunol Res       Date:  2017-12       Impact factor: 2.829

2.  The role of MSCT angiography in early detection of lower limb arterial lesions in patients with antiphospholipid syndrome.

Authors:  Jovica Saponjski; Ljudmila Stojanovich; Jelena Petrovic; Dusan Saponjski
Journal:  Immunol Res       Date:  2017-04       Impact factor: 2.829

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.